Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 83 EP applications Michel Brodbeck has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after September 22, 2014). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12788199

RESPONSIVENESS TO ANGIOGENESIS INHIBITORS

IPC classification:
C12Q 1/68
Applicant:
Life Sciences Research Partners VZW
Applicant:
F. Hoffmann-La Roche AG
Applicant:
VIB VZW
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12809640

BLOOD PLASMA BIOMARKERS FOR BEVACIZUMAB COMBINATION THERAPIES FOR TREATMENT OF BREAST CANCER

IPC classification:
G01N 33/574
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12795799

ANTIBODY FORMULATION

IPC classification:
A61K 39/395, C07K 16/28
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12806322

ION EXCHANGE MEMBRANE CHROMATOGRAPHY

IPC classification:
C07K 1/18
Applicant:
Genentech, Inc.
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
The patent has been granted
EP12816206

ARTICLES OF MANUFACTURE AND METHODS FOR CO-ADMINISTRATION OF ANTIBODIES

IPC classification:
A61K 39/395, C07K 16/32, C07K 16/08
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13736138

BIOLOGICAL MARKERS FOR IDENTIFYING PATIENTS FOR TREATMENT WITH VEGF ANTAGONISTS

IPC classification:
A61K 39/395, A61K 39/00, C12Q 1/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
The patent has been granted
EP13701352

ANTI-LRP5 ANTIBODIES AND METHODS OF USE

IPC classification:
A61K 39/395, G01N 33/50
Applicant:
Genentech, Inc.
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP13706133

R-SPONDIN TRANSLOCATIONS AND METHODS USING THE SAME

IPC classification:
C07K 14/415
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP13713295

IMPROVED HARVEST OPERATIONS FOR RECOMBINANT PROTEINS

IPC classification:
C12P 21/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
The patent has been granted
EP13715815

ANTI-HCMV IDIOTYPIC ANTIBODIES AND USES THEREOF

IPC classification:
G01N 33/68, C07K 16/42
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13714129

DIAGNOSIS AND TREATMENTS RELATING TO HER3 INHIBITORS

IPC classification:
C07K 16/28
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13769258

DIAGNOSTIC METHODS AND COMPOSITIONS FOR TREATMENT OF CANCER

IPC classification:
A61K 39/395
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP13729174

METHODS OF TREATING CANCER USING PD-L1 AXIS BINDING ANTAGONISTS AND VEGF ANTAGONISTS

IPC classification:
A61K 39/395, C07K 16/28, C07K 16/22
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Genentech, Inc.
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP14193190

Tumor tissue based biomarkers for bevacizumab combination therapies

IPC classification:
A61K 39/395, G01N 33/574
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP13733496

METHODS FOR INACTIVATION OF VIRUSES AND BACTERIA IN CELL CULTURE MEDIA

IPC classification:
C12N 5/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Rebecca Marie Tollervey, Mewburn Ellis LLP
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
PATENT GRANTED
EP13730890

BLOOD PLASMA BIOMARKERS FOR BEVACIZUMAB COMBINATION THERAPIES FOR TREATMENT OF BREAST CANCER

IPC classification:
A61K 35/00, G01N 33/574
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP13734091

CELL PENETRATING PEPTIDES TO TARGET EIF4E

IPC classification:
C07K 14/47
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP13751040

ANTI-JAGGED ANITBODIES AND METHODS OF USE

IPC classification:
A61K 39/395, C07K 16/30, C07K 16/28, A61P 35/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
The patent has been granted
EP13748450

COMBINATION THERAPY FOR THE TREATMENT OF GLIOBLASTOMA

IPC classification:
A61K 39/395
Applicant:
F. Hoffmann-La Roche AG
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
The patent has been granted
EP13763162

METHODS AND COMPOSITIONS FOR PRODUCING INDUCED HEPATOCYTES

IPC classification:
G01N 33/50, C12N 5/071
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP13773482

METHODS AND COMPOSITIONS FOR PREVENTING NORLEUCINE MISINCORPORATION INTO PROTEINS

IPC classification:
C12R 1/19, C12P 21/02, C12N 9/10
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
The patent has been granted
EP13795394

ENRICHMENT OF ANTIGEN-SPECIFIC PLASMABLASTS

IPC classification:
G01N 33/569, C12N 5/0781, C07K 16/10
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP13855528

IONIC STRENGTH-MEDIATED pH GRADIENT ION EXCHANGE CHROMATOGRAPHY

IPC classification:
G01N 33/50, G01N 30/96, G01N 30/34, C07K 1/18
Applicant:
F. Hoffmann-La Roche SA
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP13818602

PREDICTION OF MOLECULAR BIOACTIVATION

IPC classification:
G06F 19/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
GRANT OF PATENT INTENDED
EP14709146

LIQUID CULTURING OF EPITHELIAL STEM CELLS

IPC classification:
C12N 5/071
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP14721668

CELL CULTURE COMPOSITIONS WITH ANTIOXIDANTS AND METHODS FOR POLYPEPTIDE PRODUCTION

IPC classification:
C12N 5/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP14717341

COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF HEPATIC CANCERS

IPC classification:
A61K 39/00, A61P 35/00, C07K 16/28
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP14709646

COMPOUNDS FOR IMPROVED STEM CELL DIFFERENTIATION INTO HEPATOCYTES

IPC classification:
C07D 401/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
The patent has been granted
EP14763258

CELL CULTURE MEDIA AND METHODS OF ANTIBODY PRODUCTION

IPC classification:
C12N 5/00, C07K 16/00, A61K 39/395
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP14772646

ANTIBODY FORMULATIONS

IPC classification:
A61K 39/395
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP14724046

TRIMERIC ANTIGEN BINDING MOLECULES

IPC classification:
C07K 16/40, C07K 16/28
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP14840968

COMBINATION THERAPY FOR THE TREATMENT OF GLIOBLASTOMA

IPC classification:
A61K 39/395, A61K 39/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
The patent has been granted
EP14784169

ANTI-PDL1 ANTIBODY FORMULATIONS

IPC classification:
A61K 39/395, C07K 16/28
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP14824722

DUAL SPECIFIC ANTIBODIES

IPC classification:
A61K 39/395, C07K 16/46, C07K 16/24
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP14830759

METHODS OF TREATING CANCER USING PD-1 AXIS BINDING ANTAGONISTS AND AN ANTI-CD20 ANTIBODY

IPC classification:
A61P 35/02, A61K 39/395, C07K 16/28
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP14833308

METHODS OF TREATING HER2-POSITIVE CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND ANTI-HER2 ANTIBODIES

IPC classification:
A61K 31/337, C07K 16/28
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
EXAMINATION IN PROGRESS
EP16171215

ANTI-ANGIOGENESIS THERAPY FOR THE TREATMENT OF PREVIOUSLY TREATED BREAST CANCER

IPC classification:
A61P 35/00, A61K 39/395
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Agent:
Christopher Marcus Denison, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15706124

ANTI-JAGGED1 ANTIBODIES AND METHODS OF USE

IPC classification:
A61P 35/00, C07K 16/28
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
The patent has been granted
EP15720712

METHOD FOR DIFFERENTIATION OF PLURIPOTENT STEM CELLS INTO CARDIOMYOCYTES

IPC classification:
C12N 5/077
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15789583

PRODUCTION OF HETEROMULTIMERIC PROTEINS USING MAMMALIAN CELLS

IPC classification:
A61K 39/00, C12P 21/08, C12P 21/04, C12N 5/07
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15744808

DIAGNOSTIC METHODS AND COMPOSITIONS FOR TREATMENT OF GLIOBLASTOMA

IPC classification:
C12Q 1/68
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15747647

COMPOSITIONS FOR TREATING CANCER USING PD-1 AXIS BINDING ANTAGONISTS AND MEK INHIBITORS

IPC classification:
C07K 16/28, A61K 39/395
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
EXAMINATION REQUESTED
EP15780971

METHODS OF TREATING CANCER USING PD-1 AXIS BINDING ANTAGONIST AND IL-17 BINDING ANTAGONISTS

IPC classification:
A61K 39/00, A61P 35/00, G01N 33/574, C07K 16/28, C07K 16/24
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP15772124

ANTIBODY FORMULATIONS

IPC classification:
C07K 16/22, A61K 39/395
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP17155514

METHODS FOR VIRAL INACTIVATION AND OTHER ADVENTITIOUS AGENTS

IPC classification:
C12N 5/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Rebecca Marie Tollervey, Mewburn Ellis LLP
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
The application has been published
EP15798303

ANIMAL MODEL FOR NEPHROPATHY AND AGENTS FOR TREATING THE SAME

IPC classification:
A61K 49/00, C07K 14/775, C07K 16/18, C12N 15/85, A01K 67/027
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
The patent has been granted
EP15797972

COMMON LIGHT CHAINS AND METHODS OF USE

IPC classification:
A61P 35/00, A61K 39/395, C07K 16/46, C07K 16/30, C07K 16/28
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP15797970

T CELL ACTIVATING BISPECIFIC ANTIGEN BINDING MOLECULES AGIANT FOLR1 AND CD3

IPC classification:
A61P 35/00, A61K 39/395, C07K 16/46, C07K 16/28
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP15804652

ANTI-TRANSFERRIN RECEPTOR ANTIBODIES AND METHODS OF USE

IPC classification:
A61P 25/00, A61K 39/395, C12N 15/13, C07K 16/46, C07K 16/40, C07K 16/28
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP15797954

COMBINATION THERAPY OF T CELL ACTIVATING BISPECIFIC ANTIGEN BINDING MOLECULES CD3 ABD FOLATE RECEPTOR 1 (FOLR1) AND PD-1 AXIS BINDING ANTAGONISTS

IPC classification:
A61K 39/00, C07K 16/28
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP15820347

ANTI-STAPHYLOCOCCUS AUREUS ANTIBODY RIFAMYCIN CONJUGATES AND USES THEREOF

IPC classification:
A61K 47/69
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP15823221

METHODS AND COMPOSITIONS FOR TREATING CANCER USING PD-1 AXIS ANTAGONISTS AND HPK1 ANTAGONISTS

IPC classification:
A61P 35/00, A61K 31/00, C07K 16/28
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP15816323

ANTI-CD79b ANTIBODIES AND METHODS OF USE

IPC classification:
A61P 35/00, A61P 35/02, A61K 39/395, A61K 47/50, C07K 16/28
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
The patent has been granted
EP15831090

THERAPEUTIC, DIAGNOSTIC AND PROGNOSTIC METHODS FOR CANCER OF THE BLADDER

IPC classification:
C12Q 1/68
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP16712126

ULTRAPURIFIED DSBA AND DSBC AND METHODS OF MAKING AND USING THE SAME

IPC classification:
G01N 33/68, G01N 33/53, C07K 1/113, C07K 1/20, C07K 1/18, C07K 1/16, C12N 9/90, C12N 9/02
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP16717751

ANTIGEN BINDING COMPLEX HAVING AGONISTIC ACTIVITY AND METHODS OF USE

IPC classification:
C07K 16/32, A61K 39/00, C07K 16/28
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP16724821

THERAPEUTIC AND DIAGNOSTIC METHODS FOR CANCER

IPC classification:
A61K 39/00, G01N 33/574, C07K 16/28
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP17194505

ANTI-MESOTHELIN ANTIBODIES AND IMMUNOCONJUGATES

IPC classification:
A61P 35/00, A61K 39/395, C07K 16/30
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP17167800

METHODS OF PURIFYING POLYPEPTIDES

IPC classification:
G01N 31/00, G01N 30/02, A61K 38/00, C07K 1/18, C07K 1/16
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP16728525

PD-L1 PROMOTER METHYLATION IN CANCER

IPC classification:
C12Q 1/68
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP16732373

THERAPEUTIC AND DIAGNOSTIC METHODS FOR CANCER

IPC classification:
C12Q 1/68
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP17195123

METHOD TO IMPROVE VIRUS REMOVAL IN PROTEIN PURIFICATION

IPC classification:
C07K 1/36, C07K 1/34, C07K 1/18, C07K 16/06
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP16736010

TRISPECIFIC ANTIBODIES SPECIFIC FOR HER2 AND A BLOOD BRAIN BARRIER RECEPTOR AND METHODS OF USE

IPC classification:
A61K 39/00, A61P 35/00, C07K 16/28, C07K 16/32
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP16730405

CELL BASED ASSAY FOR DETERMINING ANTIBODY OR LIGAND BINDING AND FUNCTION

IPC classification:
G01N 33/68, G01N 33/542, G01N 33/50
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP17202575

MMUNOGLOBULIN VARIANTS WITH ALTERED BINDING TO PROTEIN A

IPC classification:
C07K 16/32, C07K 16/00, A61K 39/395, C07K 16/12, C07K 14/31
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP16801625

METHODS OF MEASURING FACTOR D ACTIVITY AND POTENCY OF FACTOR D INHIBITORS

IPC classification:
G01N 33/542, C12Q 1/37
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP16797693

METHODS OF MAKING FUCOSYLATED AND AFUCOSYLATED FORMS OF A PROTEIN

IPC classification:
C07K 14/435
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP16798672

METHODS FOR DETERMINING THE EFFICACY PROFILE OF A DRUG CANDIDATE

IPC classification:
G01N 33/50, C12N 5/0797, C12N 5/0793
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP16797824

STANDARDIZED NEURONAL CELL ASSAYS FROM PRIMATE SPECIES

IPC classification:
G01N 33/50, C12N 5/0797, C12N 5/0793
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP17707557

OBINUTUZUMAB AND RITUXIMAB VARIANTS HAVING REDUCED ADCP

IPC classification:
A61K 39/00, C07K 16/28
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP17707558

OBINUTUZUMAB VARIANTS HAVING ALTERED CELL DEATH INDUCTION

IPC classification:
A61K 39/00, C07K 16/28
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP17711223

PROTEASE-ACTIVATED T CELL BISPECIFIC MOLECULES

IPC classification:
C07K 16/32, C07K 16/30, C07K 16/28, C07K 16/42, C07K 16/46
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP18173630

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

IPC classification:
C07K 19/00, C07K 14/47, C07K 16/32, A61P 35/00, C07K 16/46, C07K 16/28, C07K 16/30
Applicant:
Roche Glycart AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP17718767

DIAGNOSTIC AND THERAPEUTIC METHODS FOR CANCER

IPC classification:
C12Q 1/68
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP17724513

ANTIGEN BINDING MOLECULES COMPRISING A TNF FAMILY LIGAND TRIMER AND A TENASCIN BINDING MOIETY

IPC classification:
C07K 14/715, C07K 16/24
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP17725190

MODIFIED ANTI-TENASCIN ANTIBODIES AND METHODS OF USE

IPC classification:
C07K 16/18
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP17739384

DIAGNOSTIC AND THERAPEUTIC METHODS FOR CANCER

IPC classification:
C12Q 1/68
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP17735332

ANTI-POLYUBIQUITIN MULTISPECIFIC ANTIBODIES

IPC classification:
C07K 16/40, C07K 16/18
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP17743428

USE OF HUMAN EPIDIDYMIS PROTEIN 4 (HE4) FOR ASSESSING RESPONSIVENESS OF MUC 16-POSITIVE CANCER TREATMENT

IPC classification:
C07K 16/30, G01N 33/574
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP17743027

NON-HUMAN PRIMATE INDUCED PLURIPOTENT STEM CELL DERIVED HEPATOCYTES AND USES THEREOF

IPC classification:
C12N 5/071
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP17780550

SELECTIVE PEPTIDE INHIBITORS OF FRIZZLED

IPC classification:
A61K 38/10, C07K 7/00, A61K 38/03
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
Request for examination was made
EP18206718

OVERLOAD AND ELUTE CHROMATOGRAPHY

IPC classification:
C07K 1/22, B01D 15/42, C07K 1/18, C07K 1/16, C07K 16/00, B01D 15/38, B01D 15/36, B01D 15/32, B01D 15/14, B01D 15/08
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
The application has been published
EP18213796

CELL CULTURE COMPOSITIONS AND METHODS FOR POLYPEPTIDE PRODUCTION

IPC classification:
C12N 5/00
Applicant:
F. Hoffmann-La Roche AG
Agent:
Michel Brodbeck, F. Hoffmann-La Roche AG
Status:
The application has been published

Please Sign in to use this feature